XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/national/2019/11/29/biotech-vc-down-20-in-us-as-policies-drive-away-foreign-investors-bio/60%Monthly2019-12-03 03:22
https://xconomy.com/national/2019/11/27/astrazeneca-novoheart-to-co-develop-new-heart-model/60%Monthly2019-11-27 14:11
https://xconomy.com/san-diego/2019/11/26/la-jolla-pharmas-share-price-halves-on-trial-end-ceo-departure/60%Monthly2019-11-26 22:11
https://xconomy.com/national/2019/11/26/ai-startup-healx-looks-to-find-repurposable-drugs-for-rare-diseases/60%Monthly2019-11-26 16:11
https://xconomy.com/san-diego/2019/11/26/phoenixmd-adds-seed-funding-to-test-experimental-breast-cancer-drug/60%Monthly2019-12-10 01:10
https://xconomy.com/san-francisco/2019/11/25/global-bloods-sickle-cell-drug-wins-fda-approval-ahead-of-schedule/60%Monthly2019-11-26 01:19
https://xconomy.com/boston/2019/11/25/ferring-and-blackstone-team-up-to-fund-gene-therapy-firm-with-570m/60%Monthly2019-11-26 02:37
https://xconomy.com/national/2019/11/25/five-questions-with-a16zs-vijay-pande-on-ai-and-making-new-drugs/60%Monthly2019-11-25 18:05
https://xconomy.com/boston/2019/11/25/axcella-taps-incytes-laurent-chardonnet-as-chief-financial-officer/60%Monthly2019-11-25 14:13
https://xconomy.com/new-york/2019/11/25/novartis-to-acquire-medco-and-fda-ready-cholesterol-drug-for-9-7b/60%Monthly2019-11-25 14:40
https://xconomy.com/boston/2019/11/22/kymera-promotes-nello-mainolfi-to-president-ceo/60%Monthly2019-11-23 00:03
https://xconomy.com/san-francisco/2019/11/22/immune-onc-therapeutics-adds-paul-woodard-and-an-song-to-c-suite/60%Monthly2019-11-22 23:55
https://xconomy.com/national/2019/11/22/bio-roundup-so-long-celgene-rnais-arrival-pharma-in-2020-more/60%Monthly2019-11-22 16:20
https://xconomy.com/boston/2019/11/21/with-cell-by-cell-take-on-drug-discovery-immunitas-debuts-with-39m/60%Monthly2019-11-22 03:43
https://xconomy.com/new-york/2019/11/21/azitra-names-bertonis-as-chief-operating-officer/60%Monthly2019-11-22 13:27
https://xconomy.com/boston/2019/11/21/former-shire-exec-robertson-joins-yumanity/60%Monthly2019-11-22 13:25
https://xconomy.com/new-york/2019/11/20/ex-novartis-cell-gene-therapy-exec-chou-joins-aruvant-as-ceo/60%Monthly2019-11-21 04:17
https://xconomy.com/boston/2019/11/20/relay-therapeutics-names-ben-wolf-chief-medical-officer/60%Monthly2019-11-21 18:23
https://xconomy.com/boston/2019/11/20/alnylam-gets-quick-fda-ok-for-second-rnai-rare-disease-drug/60%Monthly2019-11-21 16:41
https://xconomy.com/san-francisco/2019/11/20/twist-bioscience-promotes-patrick-finn-to-chief-commercial-officer/60%Monthly2019-11-20 23:19
https://xconomy.com/san-francisco/2019/11/20/kronos-bio-appoints-jorge-dimartino-as-its-chief-medical-officer/60%Monthly2019-11-20 23:27
https://xconomy.com/san-francisco/2019/11/20/liquid-biopsy-firm-lucene-plans-bay-area-buildout-of-with-20m-in-tow/60%Monthly2019-11-20 21:56
https://xconomy.com/national/2019/11/20/biopharma-execs-remain-optimistic-despite-political-headwinds/60%Monthly2019-11-20 16:23
https://xconomy.com/boston/2019/11/20/france-based-tissium-boosts-us-work-after-closing-e38-75m-series-b/60%Monthly2019-11-20 16:25
https://xconomy.com/san-francisco/2019/11/19/myovant-to-seek-fda-ok-on-pill-to-treat-advanced-prostate-cancer/60%Monthly2019-12-12 23:05
https://xconomy.com/national/2019/11/19/reata-rakes-in-505m-to-advance-development-of-two-rare-disease-drugs/60%Monthly2019-11-19 18:41
https://xconomy.com/boston/2019/11/19/novo-ventures-sows-25m-into-accelerator-to-break-into-illustrious-mass-bio-space/60%Monthly2019-11-19 18:34
https://xconomy.com/boston/2019/11/18/inozyme-pharma-names-pedro-huertas-chief-medical-officer/60%Monthly2019-11-19 04:17
https://xconomy.com/boston/2019/11/18/verseau-therapeutics-names-tim-smith-chief-business-officer/60%Monthly2019-11-19 04:13
https://xconomy.com/new-york/2019/11/18/with-inflection-year-ahead-ovid-adds-novartiss-tardio-to-c-suite/60%Monthly2019-11-18 22:43
https://xconomy.com/san-francisco/2019/11/18/underdog-launches-with-4m-to-target-toxic-form-of-cholesterol/60%Monthly2019-11-18 20:31
https://xconomy.com/boston/2019/11/18/alkermes-eyes-brain-disorders-and-beyond-with-100m-deal-for-rodin/60%Monthly2019-11-23 00:08
https://xconomy.com/boston/2019/11/15/restorbios-respiratory-drug-flunks-phase-3-test-shattering-shares/60%Monthly2019-11-22 19:24
https://xconomy.com/national/2019/11/15/biotech-roundup-gottlieb-v-juul-solid-slumps-avidity-gets-100m-more/60%Monthly2019-12-14 01:24
https://xconomy.com/san-diego/2019/11/15/dare-to-add-microchip-based-birth-control-to-womens-health-portfolio/60%Monthly2019-11-15 07:00
https://xconomy.com/san-diego/2019/11/14/equillium-names-chief-business-officer-bruce-steel-as-successor-ceo/60%Monthly2019-11-15 00:04
https://xconomy.com/san-francisco/2019/11/14/startup-x-37-raises-14-5m-to-expand-on-ai-powered-drug-discovery/60%Monthly2019-11-14 17:46
https://xconomy.com/boston/2019/11/14/bayer-and-dewpoint-ink-deal-for-drugs-rd-at-new-frontier-of-biology/60%Monthly2019-11-14 17:17
https://xconomy.com/san-diego/2019/11/13/calporta-started-by-avalon-ventures-gsk-is-acquired-by-merck/60%Monthly2019-11-13 17:28
https://xconomy.com/san-diego/2019/11/13/avidity-bio-adds-100m-to-advance-rd-of-muscle-disorder-drugs/60%Monthly2019-11-13 17:32
https://xconomy.com/san-francisco/2019/11/13/parenteral-drug-association-west-coast-life-science-holidays-party-expo/60%Monthly2019-11-13 15:17
https://xconomy.com/boston/2019/11/12/nibrs-raman-departs-for-chief-biz-dev-role-at-flagship-pioneering/60%Monthly2019-11-12 23:07
https://xconomy.com/texas/2019/11/12/reatas-kidney-drug-hits-goals-of-key-study-paves-way-for-fda-filing/60%Monthly2019-11-12 18:51
https://xconomy.com/boston/2019/11/12/fda-again-halts-solid-bios-duchenne-gene-therapy-clinical-trial/60%Monthly2019-11-12 16:54
https://xconomy.com/raleigh-durham/2019/11/11/transenterix-ceo-pope-steps-down-fernando-appointed-successor/60%Monthly2019-11-11 20:40
https://xconomy.com/san-diego/2019/11/11/neurana-pharmaceuticals-appoints-randall-kaye-chief-medical-officer/60%Monthly2019-11-11 20:00
https://xconomy.com/national/2019/11/11/roche-challenger-to-biogens-sma-drug-succeeds-in-pivotal-study/60%Monthly2019-11-13 17:41
https://xconomy.com/san-francisco/2019/11/11/neuroscience-is-taking-the-spotlight-at-xconomys-bay-area-xchange/60%Monthly2019-11-11 20:58
https://xconomy.com/national/2019/11/08/looking-to-level-up-in-nash-novo-nordisk-licenses-ube-drug-candidate/60%Monthly2019-11-09 01:08
https://xconomy.com/new-york/2019/11/08/anemia-drug-from-acceleron-pharma-and-celgene-wins-fda-approval/60%Monthly2019-11-08 23:49
https://xconomy.com/national/2019/11/08/bio-roundup-feds-sue-gilead-biogen-eyes-china-crisprd-kidneys-more/60%Monthly2019-11-08 15:55
https://xconomy.com/national/2019/11/07/odylia-therapeutics-names-ashley-winslow-its-chief-scientific-officer/60%Monthly2019-11-08 00:47
https://xconomy.com/national/2019/11/07/teva-pharmaceutical-appoints-eli-kalif-as-new-chief-financial-officer/60%Monthly2019-11-08 00:34
https://xconomy.com/san-francisco/2019/11/07/gileads-luisa-stamm-named-assembly-biosciences-chief-medical-officer/60%Monthly2019-11-07 23:22
https://xconomy.com/boston/2019/11/07/rubius-exec-dowden-departs-for-entrada-chief-operating-officer-post/60%Monthly2019-11-07 23:16
https://xconomy.com/boston/2019/11/07/egenesis-lands-100m-to-advance-crispr-ed-pig-kidney-to-human-test/60%Monthly2019-11-07 21:11
https://xconomy.com/boston/2019/11/07/arkuda-unveils-44m-and-a-protein-restoration-approach-to-dementia/60%Monthly2019-11-07 18:03
https://xconomy.com/wisconsin/2019/11/07/ai-can-unlock-health-datas-potential-but-access-is-still-difficult/60%Monthly2019-10-25 13:32
https://xconomy.com/boston/2019/11/06/3-changes-we-should-make-to-address-the-gender-pay-gap-in-medicine/60%Monthly2019-11-06 19:55
https://xconomy.com/national/2019/11/06/astrazeneca-chooses-china-for-rd-and-ai-centers-1b-biotech-fund/60%Monthly2019-11-08 07:48
https://xconomy.com/boston/2019/11/06/biogen-adds-two-more-biosimilars-in-100m-deal-with-samsung-bioepis/60%Monthly2019-11-06 14:48
https://xconomy.com/national/2019/11/06/ge-healthcare-opens-startup-labs-at-former-astrazeneca-uk-rd-site/60%Monthly2019-11-07 03:03
https://xconomy.com/san-diego/2019/11/05/why-steve-kafka-left-third-rock-ventures-for-up-and-comer-section-32/60%Monthly2019-11-05 23:52
https://xconomy.com/san-diego/2019/11/04/with-9-5m-intrepida-bio-launches-to-target-pancreatic-cancer-more/60%Monthly2019-11-04 23:00
https://xconomy.com/detroit-ann-arbor/2019/11/04/stryker-adds-to-trauma-extremities-biz-with-4b-wright-medical-deal/60%Monthly2019-11-04 22:26
https://xconomy.com/san-diego/2019/11/04/acadia-names-subbiah-chief-medical-officer-head-of-medical-affairs/60%Monthly2019-11-04 17:30
https://xconomy.com/san-francisco/2019/11/04/gileads-sung-lee-joins-sangamo-therapeutics-as-cfo/60%Monthly2019-11-04 17:21
https://xconomy.com/boston/2019/11/04/checkmate-pharma-names-kleem-chaudhary-chief-business-officer/60%Monthly2019-11-04 17:14
https://xconomy.com/san-diego/2019/11/04/halozyme-to-restructure-after-pancreatic-cancer-drug-fails-in-phase-3/60%Monthly2019-11-04 16:55
https://xconomy.com/boston/2019/11/01/entasiss-isaacs-to-retire-altarac-appointed-chief-medical-officer/60%Monthly2019-11-01 21:17
https://xconomy.com/raleigh-durham/2019/11/01/aerie-names-david-hollander-chief-research-development-officer/60%Monthly2019-11-04 17:00
https://xconomy.com/national/2019/11/01/biotech-roundup-novartis-on-hold-amag-vote-neuro-news-more/60%Monthly2019-11-01 12:25